SynthesisBMC pulmonary medicine2023

The safety and efficacy of tislelizumab, alone or in combination with chemotherapy, for the treatment of non-small cell lung cancer: a systematic review of clinical trials.

Amin Daei Sorkhabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.